Aquestive Therapeutics: Strong Buy Rating Driven by Robust Revenue Performance and Strategic Positioning in Allergy Treatment

TipRanksNov 7 02:06 ET · Ratings

Aquestive Therapeutics Advances Drug Candidates Amid Challenges

TipRanksNov 6 16:40 ET

Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10

Moomoo NewsNov 6 09:33 ET · Ratings

H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 6 06:31 ET · Ratings

Promising Future and Strategic Advancements: Buy Recommendation for Aquestive Therapeutics

TipRanksNov 6 06:25 ET

Aquestive Therapeutics, Inc. (AQST) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 5 16:36 ET · Conference Call